REST EZ Inc.
RTEZOTCHealthcare · Pharmaceutical Preparations · WY · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $0 | $5,000 | $0 | $519,443 | $105,000 |
| Operating income | −$7,900 | −$19,386 | −$418,408 | $223,642 | −$12,580 |
| Net income | −$7,900 | −$19,386 | −$428,706 | $171,971 | −$23,222 |
| Total assets | $300 | $13,500 | $2,594 | $407,981 | $118,950 |
| Total liabilities | — | — | — | — | — |
| Equity | $300 | −$36,805 | −$170,564 | $247,844 | −$14,111 |
| EPS (diluted) | $0.00 | $0.00 | $-0.02 | $0.01 | $0.00 |
| Shares out. | 27.5M | 20.0M | 20.0M | 20.0M | 27.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −2633.3%
- Return on assets
- −2633.3%
- Return on capital (ROCE)
- −2633.3%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.00
- Revenue growth (YoY)
- −100.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 12268.3%high accruals
- Piotroski F-Score
- 0/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 15, 2022
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2022
- NT 10-Kmissed a reporting deadline ↗Jul 1, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1 | 1000.0 | 0.0% |
| Apr 30, 2026 | 1 | 1000.0 | 0.0% |
| Apr 15, 2026 | 1 | 1000.0 | 0.0% |
| Mar 31, 2026 | 1 | 1000.0 | 0.0% |
| Mar 13, 2026 | 1 | 1000.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventJul 10, 2025
- Other material eventJul 9, 2025
- Changed auditorSep 26, 2023
- Changed auditorJun 21, 2022
- Changed auditorJan 31, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QFORM 10-QFeb 10, 2026
- 10-QFORM 10-QDec 23, 2025
- 10-QFORM 10-QDec 23, 2025
- 10-KFORM 10-KDec 16, 2025
- 8-KFORM 8-KJul 10, 2025
- 8-KREST EZ 8-KJul 9, 2025
- DJul 7, 2025
- 10-QFORM 10-QApr 25, 2025
- 10-QFORM 10-QApr 25, 2025
- 10-QFORM 10-QApr 25, 2025
- 10-KFORM 10-KFeb 13, 2025
- 10-QFORM 10-QMar 7, 2024
- 10-QFORM 10-QJan 16, 2024
- DDec 20, 2023
- PRE 14CFORM PRE 14CSep 29, 2023